XML 32 R17.htm IDEA: XBRL DOCUMENT v3.26.1
GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS
 12 Months Ended
Jun. 30, 2026
Intangible Asset, Goodwill and Other [Abstract]  
GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS
The changes in the carrying amount of goodwill by reportable segment and Corporate and Other for the fiscal years ended June 30, 2026 and 2025 were as follows:
Goodwill
Health and WellnessHouseholdLifestyleInternationalCorporate and OtherTotal
Balance as of June 30, 2024$323 $85 $244 $576 $— $1,228 
Effect of foreign currency translation— — — 1 — 1 
Balance as of June 30, 2025323 85 244 577 — 1,229 
Acquisitions717 — — — — 717 
Effect of foreign currency translation— — — (1)— (1)
Balance as of June 30, 2026$1,040 $85 $244 $576 $— $1,945 
The changes in the carrying amount of trademarks and other intangible assets for the fiscal years ended June 30, 2026 and 2025 were as follows:
As of June 30, 2026As of June 30, 2025
Gross carrying amountAccumulated amortization / ImpairmentsNet carrying amountGross carrying amountAccumulated amortization / ImpairmentsNet carrying amount
Trademarks, net:
Trademarks with indefinite lives(1)
$959 $— $959 $493 $— $493 
Trademarks with finite lives (1)
58 28 30 33 24 9 
$1,017 $28 $989 $526 $24 $502 
Other intangibles, net:
Customer-related assets with finite lives (1)
$619 $72 $547 $71 $63 $8 
Other intangible assets with finite lives (1)
421 362 59 397 341 56 
$1,040 $434 $606 $468 $404 $64 
(1)Increase of Trademarks with indefinite lives, Trademarks with finite lives, Customer-related assets with finite lives and Other intangible assets with finite lives is primarily related to the acquisition of GOJO Industries, Inc. See Note 2 for additional details.
Amortization expense relating to the Company’s intangible assets was $28, $21 and $29 for the years ended June 30, 2026, 2025 and 2024, respectively. Estimated amortization expense for these intangible assets is $52, $51, $34, $34 and $34 for fiscal years 2027, 2028, 2029, 2030 and 2031, respectively.
No material impairments were identified as a result of the Company's impairment reviews during fiscal years 2026, 2025 and 2024.